The purpose of this study was to identify the differences in angiogenesis gene expression between normal and diabetic keratocytes stimulated with interleukin-1α (IL-1α) and tumor necrosis factor-α (TNF-α). Primarily cultured normal and diabetic keratocytes were treated with 20 ng/mL of IL-1a and TNF-α for 6 hr. cDNA was hybridized to an oligonucleotide microarray. Microarray analysis was used to identify differentially expressed genes that were further evaluated by real-time polymerase chain reaction (RT-PCR). Diabetes keratocytes overexpressed vital components of angiogenesis including Agtr1, and underexpressed components related to the blood vessel maturation, including Dcn. Cytokinetreated diabetic keratocytes differentially expressed components of angiogenesis. OLETF keratocytes after treatment with IL-1α and TNF-α showed the newly expressed 15 and 14 genes, respectively. Newly and commonly under-expressed five genes followed by treatment with both IL-1α and TNF-α were also evident. RT-PCR showed results similar to the microarray results. Agtr1 and Itga1 showed an increased expression in diabetic keratocytes compared with normal corneal keratocytes, especially after TNF-α treatment. Il6 appeared strong expression after interleukin-1α treatment, but showed down expression after TNF-α treatment. Further studies to analyze and confirm the significance of the identified angiogenetic genes of diabetes are needed. http://dx.doi.org/10. 3346/jkms.2014.29.2.265 • J Korean Med Sci 2014 29: 265-271 
INTRODUCTION
Angiogenesis is essential for many physiological processes in cluding wound healing, cell regeneration, tissue growth and de velopment, and embryonic development, and plays a very im portant role in the development of proliferative diabetic retino pathy, a serious complication of diabetes (13) . Angiogenesis or the formation of new blood vessels from existing vessels has re cently been widely studied; it has been found that various types of cytokines and growth factors, particularly vascular endothe lial growth factor (VEGF), are involved in angiogenesis (4, 5) .
It has been observed that retinal capillary closure and retinal ischemia can result in spread of angiogenic factors such as VEGF into the ischemic retina, leading to the formation of abnormal blood vessels (68). The mechanism of angiogenesis is similar in both corneal and retinal tissues. It has been reported that the VEGF is also involved in the angiogenesis of the cornea (9, 10) . Therefore, it is very important to identify the factors associated with the angiogenesis, and also studies of genes related to an giogenesis are expected to be very useful in the treatment of corneal neovascular diseases.
Accordingly, we investigated the differences in angiogenesis gene expression of keratocytes between the genetic model for OLETF in diabetic rats and the control group of normal rats. In addition, an experiment was performed to observe the angio genesisrelated genes in the inflamed cornea by treating with interleukin1α (IL1α) and tumor necrosis factorα (TNFα).
MATERIALS AND METHODS
Cell culture and cytokine treatment Fiftyweekold, genetically affected type 2 diabetic (OLETF, Ot suka LongEvans Tokushima Fatty) and normal rats were pur chased from Otsuka Pharmaceutical Company (Tokushima, Ja pan). The corneal epithelium was removed; the corneal stroma was isolated, and washed several times with saline containing antibiotics. The corneal endothelial layer was removed, and then the corneal stromal tissue was cut into small pieces and cultur ed serially in Dulbecco's modified Eagle medium (DMEM, Gib co BRL, Grand Island, NY, USA) containing 10% fetal bovine se rum (FBS, Gibco BRL), 100 units/mL penicillin (Gibco BRL), and 100 mg/mL streptomycin (Gibco BRL). The culture medi um was changed at 2 to 3day intervals. When the cells became confluent, the culture medium was removed, the cells were wash ed once with Dulbecco's phosphatebuffered saline (DPBS, Gibco BRL) and dissociated with 0.25% trypsin0.02% EDTA.
For the microarray experiments, cells between the third and fourth generation of serial culture were collected and stored at 70°C. The corneal stromal cells of diabetic and normal rats were treated with the cytokines, IL1α and TNFα (R&D Systems, Min neapolis, MN, USA), at a concentration of 20 ng/mL for 6 hr.
RNA extraction
Total cellular RNAs were extracted from the corneal stromal cells of diabetic and normal rats in primary culture using the RNeasy mini kit (QIAGEN Inc, Valencia, CA, USA) for gene mi croarrays. First, denaturing solution was added to cell pellets on ice for 5 min, and then phenol and chloroform were added to all samples. The samples were centrifuged, and the supernatant containing RNA was transferred to a new tube. The process was repeated. Subsequently, isopropanol at 20°C was added to precipitate the RNA, and then the mixture was centrifuged and the supernatant was discarded carefully. The pellet was washed with 80% ethanol at 20°C and then airdried. Extraction of RNA was quantitated and confirmed by electrophoresis.
DNA gene microarrays
Sixtymer oligonucleotides corresponding to each gene were synthesized and subsequently placed on a slide using a robotic gene microarray. The robotic gene microarray places 0.251 nL DNA samples on a slide sample in spots averaging 100150 nm. cDNA was synthesized from the isolated RNA samples using RT primers (Genisphere Inc, Hatfield, PA, USA) and SuperScript II reverse transcriptase (Invitrogen, Grand Island, NY, USA). The purified cDNA was hybridized to an Agilent Rat oligo 22K chip (Agilent tech, Santa Clara, CA, USA). For hybridization, slides were placed in a dark hybridization chamber at 62°C for 16 hr. The slides were removed, washed three times, and dried using a centrifuge. A fluorescent dye was added to DNA capture re agents that bind RT primers. Thereafter, the second hybridiza tion was performed for 4 hr. The slides were removed, washed, and dried using a centrifuge. Afterward, the fluorescence level was measured using an Axon Laser Fluorescence Scanner (Axon Instruments Inc, Foster City, CA, USA). The microarray analyz er we used in our study has 105 rows and 215 columns. A total of 22,575 genes pertinent to angiogenesis were included.
Analysis
The hybridized slides were scanned by an Axon GenePix Laser Fluorescence Scanner and analyzed by GenePix Pro 5.1 (Axon Instruments) and GeneSpring 7.0 (Silicongenetics, Redwood City, CA, USA). Gene expression was considered as significant for genes showing more than a twofold difference in expression level between normal and diabetic rats. Genes showing similar patterns were distinguished by a Pearson's correlation analysis. The images thus obtained show that genes that are upregulat ed are shown in red, whereas genes that are downregulated are shown in green. First of all, we investigated the differences in angiogenesis gene expression in keratocytes between dia betic and normal rats. In addition, the angiogenesisrelated genes that show different expressions between normal and dia betic keratocytes after treatment with IL1α and TNFα were also studied.
Real-time polymerase chain reaction
Realtime polymerase chain reaction (RTPCR) was performed with SYBR Green I immunofluorescence dye and the HotStar Taq DNA polymerase QuantiTect SYBR Green PCR Kit (QIA GEN GmbH, Hamburg, Germany). To quantitate the control group, a standard curve for the genes of interest and glyceralde hydes 3phosphate dehydrogenase (GAPDH) was prepared. GAPDH was reacted to three genes: Il6, Itga1, and Agtr1. The reactions were carried out using the ABI PRISM 7900 Sequence Detection System version 1.6 software (PerkinElmer Biosys tems, Foster City, CA, USA). Relative quantificational measure ments were performed using the relative standard curve meth od according to the manufacturer's instructions.
RESULTS
The subjects used in our study were 50weekold diabetic OLETF rats. Mean blood glucose was 115.0 ± 10.8 mg/dL in the control group and 193.8 ± 18.9 mg/dL in the OLETF group, which dem onstrated statistically significant differences between the two groups. Mean body weight was significantly higher in the OLETF group (control group: 518.0 ± 13.3 g; OLETF group: 628.5 ± 63.2 g). These are the typical characteristics of diabetic rats.
Diabetic keratocytes showed upward expression in 13 genes related to angiogenesis, compared to normal keratocytes, inclu ding the Vegfc, Agtr1, Itga1, Ddah1, Adora2b, and Cspg4. Twen tytwo genes including the Mmp3, Dcn, Amotl2, and Pdgfa were downregulated (Table 1) .
Three genes in diabetic keratocytes, namely Itga1, Ddah1, and Pttg1, which promoted angiogenesis, showed an increased expression after both cytokine treatments, as well as compared to normal keratocytes. Genes that showed a decreased expres sion after both cytokine treatments were Mmp3 and Pdgfa.
Some genes showed different patterns of expression in re sponse to two cytokines. Itga1 showed no reaction to TNFα and responded to IL1α only. Conversely, Esm1 did not show a reaction to IL1α and indicated a decreased expression to TNFα compared to the control group (Table 1) .
Newly expressed genes after IL1α treatment are shown in Table 2 . After IL1α treatment, 15 genes showed different ex pression in diabetic keratocytes as compared to control group. Among them, eight genes showed an increased expression in cluding Egr1, Cxcl12, and Tn. Seven genes showed a decreased expression including Il1b, Pdgfra, and Klf5. Newly expressed genes after TNFα treatment are shown in Table 3 . After TNFα treatment, 14 genes showed different ex pression in diabetic keratocytes as compared to control group. TNFα treatment increased gene expression in the Agtr1, Tnmd, and C1galt1. However, 11 genes including Edn1, Mmp9, and Prok1 showed a decreased expression compared to the control group.
Newly expressed genes after both IL1α and TNFα treatment are shown in Table 4 . Five genes showed decreased gene expres sion, including tissue inhibitor of Timp3 and Mmp14. Conver sely, for Ctss, Hmox1, and Il6, which control and induce angio genesis, expression was increased by IL1α stimulation and de creased by TNFα treatment.
The RTPCR was performed on three genes: Il6, Itga1, and Agtr1 that showed significantly different expression between normal and diabetic keratocytes, or were newly expressed after cytokine treatment. The primer preparation and annealing tem perature for these genes are shown in Table 5 .
After cytokine treatment, the Itga1 significantly showed an increased expression in diabetic rats. The Agtr1 showed an in creased expression compared to normal rats, but showed no expression by IL1α treatment and increased expression by TNFα treatment. Il6 showed no expression in the keratocytes of dia betic rats, but increased expression by IL1α treatment and de creased expression by TNFα treatment (Fig. 1) .
DISCUSSION
Thirtyfive genes that showed different expressions in diabetic keratocytes compared to normal keratocytes, are related to VEGF. Table 3 . Genes up-and down-regulated for newly expressed genes following tumor necrosis factor-α treatment in cultured diabetic rat stromal keratocytes compared with normal rat stromal keratocytes Table 4 . Genes up-and down-regulated for newly expressed genes following treatment with both interleukin-1α and tumor necrosis factor-α in cultured diabetic rat stromal keratocytes compared with normal rat stromal keratocytes *A ratio of newly expressed genes associated with cell motility and communication in cultured diabetic rat stromal keratocytes compared with that of normal rat stromal keratocytes after treatment with interleukin-1α (IL-1α). † A ratio of newly expressed genes associated with cell motility and communication in cultured diabetic rat stromal keratocytes compared with that of normal rat stromal keratocytes after treatment with tumor necrosis factor-α (TNF-α).
The VEFG is one of the most important regulators of angiogen esis, and is associated with endothelial cell proliferation of an giogenesis process (11) . Activated angiogenic process from de creased blood supply to organs and tissue in diabetes, is related to the increased gene expression related to VEGF.
The angiotensin II type 1 receptor gene (Agtr1) is observed to have the highest increased expression in diabetic rats compar ed to normal rats. Angiotensin II upregulates mRNA expres sion of VEGF and potentiates VEGFmediated angiogenic ac tivity through an upregulation in kinase domain region in en dothelial cells (12, 13) . Therefore, upregulated expression of Agtr1 in corneal stromal cells results in the activation of angio genesis through the reinforcement of the VEGF action. Ferna dez et al. (14) also reported that angiotensin II induces angio genesis in the rabbit cornea, which coincides with the result of our study.
Twentytwo genes show decreased expression in diabetic keratocytes compared to normal keratocytes, and the represen tative gene is decroin (Dcn). This gene stabilizes the extracellu lar matrix assembly to provide a template for endothelial cells to form capillary tubes by interacting with specific other angio genesisassociated extracellular matrix molecules such as type I collagen and fibronectin. In addition, Dcn is also known to prevent apoptosis of endothelial cells and to be involved in mat uration of the blood vessels (1518). Therefore, downregulated expression of Dcn in diabetes suggests that normal blood vessel growth and maturation is impossible in diabetic tissues (incom plete angiogenesis). Furthermore, decorin is known to be in volved in angiogenesis, particularly in condition in which the inflammatory component is dominant (19) . This coincides with the result of our study, in which expression of Dcn increases when inflammation is induced by IL1α and TNFα treatment. In addition, angiopoietin 2 (Agpt2) and plateletderived growth factor, alpha (PDGF-α, Pdgfa) show a decreased expression, which are related to stabilization and maturation of blood ves sels through the recruitment of pericytes and vascular smooth muscle cells. The decreased expression of these genes is related to the fact that although neovascularization is stimulated in dia betes, the newly formed blood vessels are immature and are easily damaged by external stimulation.
Genes that show a significant increased expression after IL 1α and TNFα treatment include Itga1, Ddah1, and Pttg1. Integ rin alpha 1 (Itga1) is found to be directly involved in the process of angiogenesis by facilitating endothelial cell migration (20) . In addition, dimethylarginine dimethylaminohydrolase 1 (Ddah1) is known to stimulate the process of angiogenesis (21) and that pituitary tumortransforming 1 (Pttg1) induces basic fibroblast growth factor expression and thereby promoting angiogenesis (22) .
The genes that show a decreased expression, Mmp3 and Pdgfa, exhibited greater action with cytokines. The decreased ex pression of these genes implies that the recovery of diabetic tis sues and blood vessels may be delayed or cause damage due to inflammation. PDGF-α (Pdgfa) plays a critical role in vessel ma turation by recruiting vascular pericytes which aid in basal lam ina assembly. And it also prevents vascular endothelial cell apo ptosis after VEGF withdrawal (2325). An experiment on mice showed that 50% reduction of the pericyte density can cause retinopathy which is similar to diabetic retinopathy (26) . De creased expression of these genes in diabetic keratocyte might be related to the dysplasia of the vessel wall.
Among the eight angiogenesisrelated genes that show an increased expression after IL1α treatment, early growth respon se 1 (Egr1) has a direct reaction on angiogenesis through the formation, proliferation, and migration of endotheliocytes in microblood vessels (27) . Chemokine (CXC motif) ligand 12 (Cxcl12) is a potent promoter of angiogenesis that promotes re cruitment of endothelial progenitor cells from the bone mar row, and has an important role in the pathogenesis of chronic inflammatory disorders (28) . Conversely, among the angiogen esisrelated genes that are newly expressed after IL1α treatment, plateletderived growth factor receptor, alpha polypeptide (Pdgfra) and kruppellike factor 5 (Klf5) exhibited a decreased ex pression. If Pdgfra and Klf5 are insufficient during embryogen esis, the incomplete formation of blood vessels or vascular mal formation is induced by endothelial cell necrosis, significant re duction in the numbers of vessel wall pericytes and smooth muscle cells, and decreased deposition of extracellular matrix (29) . This result shows that the retinal neovascularization is ac tivated in proliferative diabetic retinopathy, but the formation of immature blood vessels promotes complications of diabetes such as hemorrhage and necrosis of normal retinal tissues. Fig. 1 . Quantitative real-time PCR of three genes using GAPDH as an endogenous control. "*" indicates a significant difference between normal and diabetic rats stimulated with or without IL-1α or TNF-α. Itga1 and Agtr1 show a significant difference between untreated normal and diabetic rat, but the diabetic rat showed significant change in the expression of Il6. Agtr1 show an increased expression in the diabetic rat treated with TNF-α. After TNFα treatment, 14 angiogenesisrelated genes are new ly expressed. As mentioned above, Agtr1, which clearly shows an increased expression, is known to increase the expression of VEGF and potentiate VEGFmediated angiogenic activity. The increased expression of tenomodulin (Tnmd) is also known as an angiogenesis inhibitor to interfere with blood vessel forma tion. The reciprocal expression of these genes demonstrated that angiogenesis is induced but the formation of complete blood vessel is impossible in inflammationrelated diabetes cases. Furthermore, the matrix metallopeptidase 9 (Mmp9) and en dothelin 1 (Edn1), which are involved in angiogenesis, show a lower expression in diabetic keratocytes after TNFα treatment as compared to the control group. This downregulate neovas cularization in diabetes, and is related to the pathological mech anism of this disease.
Newly and decreased expressed genes by IL1 α and TNFα treatment are Timp3, Mmp14, Adm, Npy, and Cited2. Adreno medullin (Adm) is recognized as a novel growth factor for en dothelial cells and promoter of angiogenesis. Neuropeptide Y (Npy) is known to stimulate angiogenesis through endothelial cell migration, proliferation, and differentiation in vitro and acts on angiogenesis for ischemic stimulation (30) . In particular, the expression of these genes decreases in diabetic rats after cyto kine treatment, which induces inflammation and delays angio genesis in diabetes. As a result, an ischemic change is caused in tissues that may lead to diabetic complications. Therefore, much more histopathologic research in this area is anticipated. More over, cathepsin (Ctss) plays a functional role in angiogenesis through the production of type IV collagenderived antiangio genic peptides and the generation of bioactive proangiogenic gamma 2 fragments from laminin5 (31); heme oxygenase 1 (Hmox1) promotes VEGFdriven noninflammatory angiogene sis (32) . In addition IL6 (Il6) shows an increased expression af ter treatment with IL1α and decreased expression after treat ment with TNFα. This result demonstrates that inflammation reactions can vary by the type of cytokine used. More studies on individual genes expressed differently after the cytokine treat ment may be necessary.
In this study, we selected three genes that showed a signifi cant difference of expression between normal and diabetic ker atocytes to create a primer and performed an RTPCR to con firm the result of microarray analysis. In other words, the RT PCR was performed on Il6 that showed an increased and de creased expression on cytokine treatment, Itga1 that showed an increased expression in diabetes compared to normal rats, and Agtr1 that clearly increased expression by TNFα treatment. The degree of expression was then examined. Consequently, the same expression pattern could be confirmed, as was the case with the microarray analysis.
The genes expressed more often in diabetic keratocytes than in normal keratocytes were found to stimulate the process of angiogenesis while at the same time forming immature blood vessels. These effects are also stimulated by newly expressed genes after the IL1α and TNFα treatment which causes infla mmation. Although much more time and effort are needed in this kind of studies, there will be an important opportunity to evaluate or identify new genes related with angiogenesis in dia betics.
